These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Combination of 13-cis retinoic acid and interferon-alpha in the treatment of recurrent or refractory peripheral T-cell lymphoma. Huang CL, Lin ZZ, Su IJ, Chao TY, Tien HF, Chang MC, Huang MC, Kao WY, Tang JL, Yeh KH, Wang CH, Hsu CH, Liu MY, Cheng AL. Leuk Lymphoma; 2002 Jul; 43(7):1415-20. PubMed ID: 12389622 [Abstract] [Full Text] [Related]
4. 13-cis retinoic acid in head and neck cancer chemoprevention: results of a randomized trial from the Italian Head and Neck Chemoprevention Study Group. Toma S, Bonelli L, Sartoris A, Mira E, Antonelli A, Beatrice F, Giordano C, Benazzo M, Caroggio A, Cavalot AL, Gandolfo S, Garozzo A, Margarino G, Schenone G, Spadini N, Sirotovà Z, Zibordi F, Balzarini F, Serafini I, Miani P, Cortesina G. Oncol Rep; 2004 Jun; 11(6):1297-305. PubMed ID: 15138569 [Abstract] [Full Text] [Related]
11. In vitro radiosensitization of human cervical carcinoma cells by combined use of 13-cis-retinoic acid and interferon-alpha2a. Ryu S, Kim OB, Kim SH, He SQ, Kim JH. Int J Radiat Oncol Biol Phys; 1998 Jul 01; 41(4):869-73. PubMed ID: 9652851 [Abstract] [Full Text] [Related]
14. National Cancer Institute (phase II) study of high-grade glioma treated with accelerated hyperfractionated radiation and iododeoxyuridine: results in anaplastic astrocytoma. Sullivan FJ, Herscher LL, Cook JA, Smith J, Steinberg SM, Epstein AH, Oldfield EH, Goffman TE, Kinsella TJ, Mitchell JB. Int J Radiat Oncol Biol Phys; 1994 Oct 15; 30(3):583-90. PubMed ID: 7928489 [Abstract] [Full Text] [Related]
15. Temozolomide combined with irradiation as postoperative treatment of primary glioblastoma multiforme. Phase I/II study. Combs SE, Gutwein S, Schulz-Ertner D, van Kampen M, Thilmann C, Edler L, Wannenmacher MM, Debus J. Strahlenther Onkol; 2005 Jun 15; 181(6):372-7. PubMed ID: 15925979 [Abstract] [Full Text] [Related]
16. A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosed high-grade glioma. Buckner JC, Schomberg PJ, McGinnis WL, Cascino TL, Scheithauer BW, O'Fallon JR, Morton RF, Kuross SA, Mailliard JA, Hatfield AK, Cole JT, Steen PD, Bernath AM. Cancer; 2001 Jul 15; 92(2):420-33. PubMed ID: 11466698 [Abstract] [Full Text] [Related]
17. High-dose BCNU and autologous progenitor cell transplantation given with intra-arterial cisplatinum and simultaneous radiotherapy in the treatment of high-grade gliomas: benefit for selected patients. Fernández-Hidalgo OA, Vanaclocha V, Vieitez JM, Aristu JJ, Rebollo J, Gúrpide A, Aramendía JM, Moreno-Palanques R, Martín-Algarra S, Subirá ML, Brugarolas A. Bone Marrow Transplant; 1996 Jul 15; 18(1):143-9. PubMed ID: 8832007 [Abstract] [Full Text] [Related]
18. Increasing radiation dose intensity using hyperfractionation in patients with malignant glioma. Final report of a prospective phase I-II dose response study. Fulton DS, Urtasun RC, Scott-Brown I, Johnson ES, Mielke B, Curry B, Huyser-Wierenga D, Hanson J, Feldstein M. J Neurooncol; 1992 Sep 15; 14(1):63-72. PubMed ID: 1335044 [Abstract] [Full Text] [Related]
19. Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trial. Shin DM, Khuri FR, Murphy B, Garden AS, Clayman G, Francisco M, Liu D, Glisson BS, Ginsberg L, Papadimitrakopoulou V, Myers J, Morrison W, Gillenwater A, Ang KK, Lippman SM, Goepfert H, Hong WK. J Clin Oncol; 2001 Jun 15; 19(12):3010-7. PubMed ID: 11408495 [Abstract] [Full Text] [Related]
20. Phase II trial with BCNU plus alpha-interferon in patients with recurrent high-grade gliomas. Brandes AA, Scelzi E, Zampieri P, Rigon A, Rotilio A, Amista P, Berti F, Fiorentino MV. Am J Clin Oncol; 1997 Aug 15; 20(4):364-7. PubMed ID: 9256890 [Abstract] [Full Text] [Related] Page: [Next] [New Search]